LeonaBio (LONA) Cash & Current Investments (2019 - 2026)

LeonaBio (LONA) has reported Cash & Current Investments for 8 consecutive years, with $67.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments rose 84.56% year-over-year to $67.7 million; the TTM figure through Mar 2026 stood at $67.7 million (up 84.56% YoY), while the FY2025 annual figure was $88.3 million, up 72.27% from the prior year.
• Cash & Current Investments fell to $67.7 million in Q1 2026 per LONA's latest filing, from $88.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $263.5 million in Q1 2022 and bottomed at $25.2 million in Q3 2025.
• Historically, Cash & Current Investments has averaged $130.0 million across 5 years, with a median of $122.1 million in 2024.
• Annual changes were most pronounced in 2025 — Cash & Current Investments tumbled 69.96% — and 2026, when it soared 84.56%.
• LeonaBio's Cash & Current Investments stood at $200.3 million in 2022, then fell by 26.42% to $147.4 million in 2023, then slumped by 65.22% to $51.3 million in 2024, then surged by 72.27% to $88.3 million in 2025, then fell by 23.38% to $67.7 million in 2026.
• Business Quant data shows LONA's Cash & Current Investments at $67.7 million in Q1 2026, $88.3 million in Q4 2025, and $25.2 million in Q3 2025.